CHAPTER 7 178 A. B. C. D. E. F. Figure S2 A-F. 5-year disease-specific survival (DSS) and recurrence-free survival (RFS) of patients with normal and abnormal haematological parameters within patients classified as intermediate risk who received VBT. A. 5-year DSS of patients with intermediate risk and VBT, and with and without anaemia. B. 5-year DSS of patients patients with intermediate risk and VBT, and with and without thrombocytosis. C. 5-year DSS of patients with intermediate risk and VBT, and with and without leucocytosis. D. 5-year RFS of patients with intermediate risk and VBT, and with and without anaemia. E. 5-year RFS of patients with intermediate risk and VBT, and with and without thrombocytosis. F. 5-year RFS of patients with intermediate risk and VBT, and with and without leucocytosis.
RkJQdWJsaXNoZXIy MTk4NDMw